Mesoblast limited (MESO) Coverage Initiated at CIBC
Investment analysts at CIBC initiated coverage on shares of Mesoblast limited (NASDAQ:MESO) in a report issued on Thursday. The brokerage set an “outperform” rating and a $16.00 price target on the stock. CIBC’s target price would indicate a potential upside of 156.41% from the stock’s current price.
A number of other research analysts have also recently commented on MESO. Zacks Investment Research cut Mesoblast limited from a “buy” rating to a “sell” rating in a research note on Wednesday, May 17th. Maxim Group set a $14.00 target price on Mesoblast limited and gave the company a “buy” rating in a research note on Thursday, May 25th. Cantor Fitzgerald initiated coverage on Mesoblast limited in a research note on Wednesday, June 7th. They issued a “buy” rating and a $20.00 target price on the stock. BidaskClub cut Mesoblast limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Finally, Credit Suisse Group set a $11.00 target price on Mesoblast limited and gave the company a “hold” rating in a research note on Tuesday, July 18th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $13.64.
Mesoblast limited (MESO) traded down 2.08% during midday trading on Thursday, hitting $6.11. The company had a trading volume of 157,031 shares. Mesoblast limited has a 52 week low of $4.01 and a 52 week high of $12.50. The firm’s 50 day moving average is $7.20 and its 200-day moving average is $8.23. The firm’s market capitalization is $518.64 million.
COPYRIGHT VIOLATION NOTICE: “Mesoblast limited (MESO) Coverage Initiated at CIBC” was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/mesoblast-limited-meso-coverage-initiated-at-cibc/1534614.html.
A hedge fund recently raised its stake in Mesoblast limited stock. Princeton Capital Management Inc. boosted its position in Mesoblast limited (NASDAQ:MESO) by 15.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 155,700 shares of the company’s stock after buying an additional 20,945 shares during the period. Princeton Capital Management Inc. owned approximately 0.20% of Mesoblast limited worth $1,398,000 as of its most recent SEC filing. 2.95% of the stock is owned by hedge funds and other institutional investors.
Mesoblast limited Company Profile
Receive News & Ratings for Mesoblast limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast limited and related companies with Analyst Ratings Network's FREE daily email newsletter.